Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003220367 | SCV003914148 | uncertain significance | Inborn genetic diseases | 2023-03-02 | criteria provided, single submitter | clinical testing | The c.2809C>A (p.Q937K) alteration is located in exon 19 (coding exon 19) of the CACNA1A gene. This alteration results from a C to A substitution at nucleotide position 2809, causing the glutamine (Q) at amino acid position 937 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |